Recent Finacing
Recent Raise
SolasCure is a Cambridge biotech developing Aurase Wound Gel, a hydrogel delivering a recombinant maggot-derived enzyme (tarumase) for enzymatic debridement of chronic wounds, currently in clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at SolasCure.
